Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5  billion deal on Thursday, its second‑largest takeover ever, ...

Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

The $15 billion acquisition of a California maker of vascular devices is Boston Scientific's biggest since 2006.

Boston Scientific is planning a new 300,000-square-foot lab and office building in Maple Grove, expanding its Arbor Lakes ...

This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.

Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...

Boston Scientific is set to acquire Penumbra, Inc. for $14.5 billion, enhancing their vascular therapy offerings.

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...